Close C F, Scott G S, Viberti G C
Unit for Metabolic Medicine, U.M.D.S., Guy's Hospital, London, UK.
Diabet Med. 1987 Sep-Oct;4(5):491-2. doi: 10.1111/j.1464-5491.1987.tb00916.x.
Subclinical elevation of urinary albumin excretion (microalbuminuria) identifies individuals at high risk of developing nephropathy in insulin-dependent diabetes. We have evaluated the performance of a new specific method for the rapid detection of microalbuminuria employing a latex agglutination inhibition technique. A total of 96 consecutive sterile first morning urine samples from insulin-dependent diabetic subjects were tested using AlbuScreen TM (Cambridge Life Sciences). Fifteen samples with albumin concentration greater than 27 micrograms/ml (range 27.6-780 micrograms/ml) read positive with AlbuScreen and were identified with 100% sensitivity and specificity. This test which is ten times more sensitive than the qualitative methods in current use and which detects a wide range of urinary albumin concentrations from microalbuminuria to heavier proteinuria may prove useful in the outpatients setting.
尿白蛋白排泄亚临床升高(微量白蛋白尿)可识别胰岛素依赖型糖尿病患者发生肾病的高风险个体。我们评估了一种采用乳胶凝集抑制技术快速检测微量白蛋白尿的新特异性方法的性能。使用AlbuScreen TM(剑桥生命科学公司)对来自胰岛素依赖型糖尿病患者的96份连续无菌晨尿样本进行了检测。15份白蛋白浓度大于27微克/毫升(范围为27.6 - 780微克/毫升)的样本经AlbuScreen检测呈阳性,且灵敏度和特异性均为100%。该检测方法比目前使用的定性方法灵敏十倍,可检测从微量白蛋白尿到重度蛋白尿的广泛尿白蛋白浓度范围,可能在门诊环境中有用。